Agriculture & Biology
adverse effects
6%
agonists
15%
antagonists
14%
brain
5%
cell lines
43%
cerebral cortex
10%
dosage
8%
glutamate receptors
46%
immunoblotting
8%
immunohistochemistry
8%
in situ hybridization
7%
in vitro studies
8%
injection
11%
learning
7%
ligands
7%
mice
19%
mitogen-activated protein kinase
9%
neuroglia
64%
neurons
49%
neurotrophins
82%
Parkinson disease
11%
phosphatidylinositol 3-kinase
11%
proteins
5%
quantitative polymerase chain reaction
6%
receptors
40%
sedation
10%
therapeutics
6%
tyrosine 3-monooxygenase
10%
Medicine & Life Sciences
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
10%
Ataxia
8%
Brain
4%
Cerebral Cortex
7%
Corpus Striatum
57%
Excitatory Amino Acid Agonists
11%
Excitatory Amino Acid Antagonists
10%
Glial Cell Line-Derived Neurotrophic Factor
78%
Immunoblotting
8%
Immunohistochemistry
5%
In Situ Hybridization
7%
In Vitro Techniques
3%
Injections
9%
Ionotropic Glutamate Receptors
11%
Knockout Mice
15%
Learning
6%
Ligands
5%
LY 341495
14%
LY 379268
74%
Messenger RNA
9%
Metabotropic Glutamate Receptors
21%
Mitogen-Activated Protein Kinases
8%
Neurons
36%
Neuroprotective Agents
8%
Parkinson Disease
7%
Parkinsonian Disorders
9%
Pars Compacta
10%
Phosphatidylinositol 3-Kinase
8%
Proteins
6%
Real-Time Polymerase Chain Reaction
6%
Therapeutics
1%
Tyrosine 3-Monooxygenase
9%
Chemical Compounds
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
13%
Agent Interacting With Transmitter, Hormone or Drug Receptor
18%
Dose
12%
Enhancer
10%
Ionotropic Receptor Antagonist
17%
Ligand
3%
Metabotropic Receptor Agonist
15%
Neuroprotective Agent
13%
Neurotrophic Factor
100%
Protective
6%
Protein
10%
Purity
4%
Tyrosine
7%